Cd19 j3 119
The CD19 (J3-119) is a lab equipment product from Beckman Coulter. It is a monoclonal antibody that recognizes the CD19 antigen, which is expressed on the surface of B cells.
Lab products found in correlation
4 protocols using cd19 j3 119
Multiparameter Flow Cytometry of Macaque Immune Cells
Multiparametric Flow Cytometry Analysis of Immune Cells
Antibodies against human CD5 (L17F12), CD8 (Sk‐1), CD21 (B‐Ly4), CD31 (WM59), CD38 (HIT2), KI‐67 (B56), PD‐1 (CD279, Clone MIH4), CXCR5 (RF8B2) were from BD Biosciences (San Jose, CA), Goat F(ab’)2 IgM and IgG from Southern Biotech(Birmingham, AL), CD19 (J3‐119) from Beckman Coulter (Fullerton, CA), CD10 (eBioCB‐CALLA), Foxp3 (PCH101) from eBiosciences (San Diego, CA), CD25 (BC96), CD127 (HCD127) from Sony biotechnology, (San Jose, CA) and CD3 (UCHT1), CD4 (RPA‐T4), CD27 (O323), CD45RO (UCHL1), CD45RA (HI100), IL‐21 (3A3‐N2) from Biolegend (San Diego, CA). Finally, stained mononuclear cells were washed twice in FACS buffer and run on an FACS Canto II and analyzed by using FlowJo software (Treestar). Naïve T cells were defined as CD3+CD45RA+CCR7+, memory T cells as CD3+ CD45RO+, Treg cells as CD3+CD4+Foxp3+, and Tfh as CD3+CD4+CXCR5+PD1+
Flow Cytometric Analysis of STLV-1 Infection
Characterization of Mesenchymal Stem Cells by Flow Cytometry
Flow cytometry was also used to study the apoptotic characteristics of MSCs at two representative passages (P2 and P6) by means of 7-aminoactinomycin D staining (7-AAD; Calbiochem-Novabiochem, Nottingham, UK) as previously described [9 (link)]. Results were expressed as proportions of 7-AADneg (live), 7-AADdim (early apoptotic) and 7-AADbright (late apoptotic) cells. Acquisition and analysis were performed in a Cytomics FC 500 flow cytometer (Beckman Coulter, Brea, CA, USA) on a minimum of 10,000 events.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!